Menu Close

How long can you take bortezomib?

How long can you take bortezomib?

You can have bortezomib on its own if you have already had treatment for myeloma. You usually have bortezomib twice a week, for 2 weeks. Then you have a break of 10 days. This 3 week period is called a cycle of treatment.

What is the most effective treatment for multiple myeloma?

Radiation therapy, which uses high-energy particles or rays to damage cancer cells and prevent them from growing, is proven to effectively treat multiple myeloma in specific situations and/or reduce complications from bone disease. Radiation therapy may also be called radiotherapy, X-ray therapy, or irradiation.

How does bortezomib treat multiple myeloma?

Bortezomib is a type of treatment for myeloma called a proteasome inhibitor. Proteasomes are enzymes found in all cells and play an important role in cell function and growth. Cancer cells are more sensitive to the effects of bortezomib, causing cancer cells to die or not grow any further.

Do you lose your hair with bortezomib?

Hair loss. Hair loss isn’t a direct side effect of Velcade, but it may be a side effect of other drugs used with Velcade. For example, hair loss may occur in people using Velcade with cyclophosphamide, which is a cytotoxic drug.

How many cycles of bortezomib are there?

Usual Adult Dose for Lymphoma -A minimum of 72 hours should elapse between consecutive doses of bortezomib. -For patients with a response first documented at cycle 6, two additional cycles (for a total of 8 cycles) are recommended.

What are the side effects of bortezomib?

Dizziness, lightheadedness, nausea, vomiting, loss of appetite, diarrhea, constipation, tiredness, weakness, or pain/redness at the injection site may occur. Nausea, vomiting, and diarrhea can be severe. In some cases, your doctor may prescribe medication to prevent or relieve nausea, vomiting, and diarrhea.

Is bortezomib a chemo drug?

VELCADE (bortezomib) is a type of chemotherapy called a targeted therapy. VELCADE belongs to a class of medicines called proteasome inhibitors. It is approved by the FDA for the treatment of multiple myeloma and mantle cell lymphoma.

How does VELCADE make you feel?